Kymera Therapeutics Statistics
Total Valuation
KYMR has a market cap or net worth of $3.49 billion. The enterprise value is $2.61 billion.
Important Dates
The next estimated earnings date is Thursday, October 30, 2025, before market open.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KYMR has 71.50 million shares outstanding. The number of shares has increased by 21.55% in one year.
| Current Share Class | 71.50M |
| Shares Outstanding | 71.50M |
| Shares Change (YoY) | +21.55% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 1.30% |
| Owned by Institutions (%) | 78.12% |
| Float | 46.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 86.45 |
| Forward PS | 59.29 |
| PB Ratio | 3.54 |
| P/TBV Ratio | 3.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 58.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.32, with a Debt / Equity ratio of 0.09.
| Current Ratio | 8.32 |
| Quick Ratio | 8.06 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -996.36 |
Financial Efficiency
Return on equity (ROE) is -33.26% and return on invested capital (ROIC) is -21.30%.
| Return on Equity (ROE) | -33.26% |
| Return on Assets (ROA) | -19.92% |
| Return on Invested Capital (ROIC) | -21.30% |
| Return on Capital Employed (ROCE) | -29.89% |
| Revenue Per Employee | $237,824 |
| Profits Per Employee | -$1.47M |
| Employee Count | 188 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.86% in the last 52 weeks. The beta is 2.18, so KYMR's price volatility has been higher than the market average.
| Beta (5Y) | 2.18 |
| 52-Week Price Change | +5.86% |
| 50-Day Moving Average | 43.62 |
| 200-Day Moving Average | 38.59 |
| Relative Strength Index (RSI) | 68.29 |
| Average Volume (20 Days) | 632,814 |
Short Selling Information
The latest short interest is 8.16 million, so 11.42% of the outstanding shares have been sold short.
| Short Interest | 8.16M |
| Short Previous Month | 7.61M |
| Short % of Shares Out | 11.42% |
| Short % of Float | 17.39% |
| Short Ratio (days to cover) | 12.97 |
Income Statement
In the last 12 months, KYMR had revenue of $44.71 million and -$275.43 million in losses. Loss per share was -$3.48.
| Revenue | 44.71M |
| Gross Profit | -246.16M |
| Operating Income | -311.86M |
| Pretax Income | -157.85M |
| Net Income | -275.43M |
| EBITDA | -305.06M |
| EBIT | -311.86M |
| Loss Per Share | -$3.48 |
Full Income StatementBalance Sheet
The company has $665.45 million in cash and $85.71 million in debt, giving a net cash position of $877.36 million or $12.27 per share.
| Cash & Cash Equivalents | 665.45M |
| Total Debt | 85.71M |
| Net Cash | 877.36M |
| Net Cash Per Share | $12.27 |
| Equity (Book Value) | 971.48M |
| Book Value Per Share | 13.77 |
| Working Capital | 640.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$251.01 million and capital expenditures -$1.91 million, giving a free cash flow of -$252.92 million.
| Operating Cash Flow | -251.01M |
| Capital Expenditures | -1.91M |
| Free Cash Flow | -252.92M |
| FCF Per Share | -$3.54 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -697.51% |
| Pretax Margin | -616.03% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.55% |
| Shareholder Yield | -21.55% |
| Earnings Yield | -7.90% |
| FCF Yield | -7.25% |
Dividend DetailsAnalyst Forecast
The average price target for KYMR is $59.25, which is 21.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $59.25 |
| Price Target Difference | 21.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 7.12% |
| EPS Growth Forecast (5Y) | 6.06% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KYMR has an Altman Z-Score of 8.39 and a Piotroski F-Score of 1.
| Altman Z-Score | 8.39 |
| Piotroski F-Score | 1 |
